Grassley: For Medicaid, Greater Transparency Will Open the Door to Better Value and Outcomes

Sen. Chuck Grassley (R-IA) recently introduced the bipartisan Prescription Drug Pricing Reduction Act of 2019. The bill provides incentives to slow the spending curve in the Medicaid drug program. Grassley says, “When states decide which drugs will be covered and included on their preferred drug lists, taxpayers and Medicaid patients ought to have assurances the system is fair. Transparency is the best guardrail to ensure safety and effectiveness to deliver the best value for taxpayers and the best outcomes for Medicaid patients.”